Trials / Completed
CompletedNCT01881347
Effects of Resveratrol on Endothelial Function in Type 2 Diabetes Mellitus
Randomized Crossover Study of The Effects of Resveratrol on Endothelial Function in Subjects With Type 2 Diabetes Mellitus
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 54 (actual)
- Sponsor
- Boston University · Academic / Other
- Sex
- All
- Age
- 21 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The present study is designed to test the hypothesis that resveratrol supplementation will improve the function of the endothelium in patients with type 2 diabetes mellitus. The function of the endothelium will be tested with a non-invasive technique that uses ultrasound to measure the amount of dilation that occurs in the brachial artery following 5-minute cuff occlusion. To help us understand potential mechanisms of benefit, we will also collect blood, urine, and cell samples and test the effects of treatment on protein expression, nitric oxide production, and function of mitochondria.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Resveratrol | Resveratrol 100 mg daily for 2 weeks followed by resveratrol 300 mg daily for 2 weeks. |
| DIETARY_SUPPLEMENT | Placebo | Placebo 100 mg daily for 2 weeks followed by placebo 300 mg daily for 2 weeks. |
Timeline
- Start date
- 2013-01-01
- Primary completion
- 2015-03-01
- Completion
- 2016-07-01
- First posted
- 2013-06-19
- Last updated
- 2018-03-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01881347. Inclusion in this directory is not an endorsement.